Modern view of colorectal cancer screening

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The objectives of screening are the diagnosis of early stages of cancer, the identification and timely removal of adenomatous polyps, and the goals are to reduce mortality and improve survival. The fundamental requirements for screening are low cost, safety, ease of implementation, high sensitivity, and specificity. It is necessary to separate approaches to screening in groups with average, increased and high risks of colorectal cancer. It is recommended that screening begin in average-risk patients at age 40 and continue until age 75. In patients with increased and high risks of colorectal cancer, the age at which screening begins and its frequency is determined individually, based on medical history and risk factors. When deciding whether to screen, it is necessary to take into account the patient’s individual preferences, risks, availability of tests and their cost. Colon cancer is a socially significant disease that can be effectively treated in its early stages. The feasibility of screening for colorectal cancer is undoubted, and the development of new methods for early diagnosis, identifying markers of early stages of carcinogenesis, is of great importance.

Full Text

Restricted Access

About the authors

R. V. Minskiy

52nd Consultative and Diagnostic Center of the Russian Defense Ministry

Author for correspondence.
Email: 52kdc@mil.ru
Russian Federation, Moscow

References

  1. Ликутов А.А. Капсульная эндоскопия в диагностике заболеваний тонкой и толстой кишки: Дис. ... канд. мед. наук. – М., 2018. – 131 с.
  2. Мартынюк В.В. Рак ободочной кишки (заболеваемость, смертность, факторы риска, скрининг) // Практ. онкология. – 2000. – Т. 1, № 1. – С. 3–9.
  3. Приказ Министерства здравоохранения РФ от 27.04.2021 № 404н «Об утверждении Порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения».
  4. Bacchus C.M., Dunfield L., Gorber S.C. et al. Recommendations on screening for colorectal cancer in primary care // CMAJ. – 2016. – Vol. 188, Iss. 5. – P. 340–348.
  5. Bibbins-Domingo K., Grossman D.C., Gurry S.J. et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement // JAMA. – 2016. – Vol. 315, N 23. – P. 2564–2575.
  6. Burt R.W., Cannon J.A., David D.S. et al. Colorectal cancer screening // J. Natl. Compr. Canc. Netw. – 2013. – Vol. 11, Iss. 12. – P. 1538–1575.
  7. Butterworth A.S., Higgins J.P., Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta- analysis // Eur. J. Cancer. – 2006. – Vol. 42, Iss. 2. – P. 216–227.
  8. Chan A.T., Giovannucci E.L. Primary prevention of colorectal cancer // Gastroenterology. – 2010. – Vol. 238, Iss. 6. – P. 2029–2043.
  9. Corley D.A., Jensen C.D., Quinn V.P. et al. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis // JAMA. – 2017. – Vol. 317, N 16. – P. 1631–1641.
  10. Doubeni C.A., Corley D.A., Levin T.R. Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test // JAMA. – 2017. – Vol. 318, N 5. – P. 483.
  11. Doubeni C.A., Laiyemo A.O., Major J.M. et al. Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study // Cancer. – 2012. – Vol. 118, Iss. 14. – P. 3636–3644.
  12. Doubeni C.A., Major J.M., Laiyemo A.O. et al. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence // J. Natl. Cancer Inst. – 2012. – Vol. 104, Iss.18. – P. 1353–1362.
  13. Gross C.P., McAvay G.J., Krumholz H.M. et al. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening // Ann. Intern. Med. – 2006. – Vol. 145, N 9. – P. 646–653.
  14. Guittet L., Bouvier V., Mariotte N. et al. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location // Br. J. Cancer. – 2009. – Vol. 100, N 8. – P. 1230–1235.
  15. Hampel H., Stephens J.A., Pukkala E. et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset // Gastroenterology. – 2005. – Vol. 129, Iss. 2. – P. 415–421.
  16. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H. et al. Multitarget stool DNA testing for colorectal-cancer screening // N. Engl. J. Med. – 2014. – Vol. 370, N 14. – P. 1287–1297.
  17. Johns L.E., Houlston R.S. A systematic review and meta-analysis of familial colorectal cancer risk // Am. J. Gastroenterol. – 2001. – Vol. 96, N 10. – P. 2992–3003.
  18. Kistler C.E., Kirby K.A., Lee D. et al. Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens // Arch. Intern. Med. – 2011. – Vol. 171, N 15. – P. 1344–1351.
  19. Kronborg O., Fenger C., Olsen j. et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test // Lancet. – 1996. – Vol. 348, Iss. 9040. – P. 1467–1471.
  20. Kumaravel V., Heald B., Lopez R. et al. Patients do not recall important details about polyps, required for colorectal cancer prevention // Clin. Gastroenterol. Hepatol. – 2013. – Vol. 11, Iss. 5. – P. 543–547.
  21. Lin J.S., Piper M.A., Perdue L.A. et al. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force // JAMA. – 2021. – Vol. 325, N 19. – P. 1978–1998.
  22. Lopes G., Stern M.C., Temin S. et al. Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline // J. Glob. Oncol. – 2019. – Vol. 5. – P. 1–22.
  23. Mecklin J.P., Aarnio M., Lааrа E. et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome // Gastroenterology. – 2007. – Vol. 133, Iss. 4. – P.1093–1098.
  24. Moreira L., Balaguer F., Lindor N. et al. Identification of Lynch syndrome among patients with colorectal cancer // JAMA. – 2012. – Vol. 308, N 15. – P. 1555–1565.
  25. Rabeneck L., Paszat L.F., Hilsden R.J. et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice // Gastroenterology. – 2008. – Vol. 135, Iss. 6. – P. 1899–1906.
  26. Rex D.K., Boland C.R., Dominitz J.A. et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer // Gastroenterology. – 2017. – Vol. 153, Iss. 1. – P. 307–323.
  27. Robertson D.J., Lee J.K., Boland C.R. et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer // Gastrointest. Endosc. – 2017. – Vol. 152, Iss. 5. – P. 1217–1237.
  28. Tang V., Boscardin W.J., Stijacic-Cenzer I. et al. Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials // BMJ. – 2015. – Vol. 350. – Р. 1662.
  29. Taylor D.P., Burt R.W, Williams M.S. et al. Population-based family history-specific risks for colorectal cancer: a constellation approach // Gastroenterology. – 2010. – Vol. 138, Iss. 3. – P. 877–885.
  30. Taylor D.P., Stoddard G.J., Burt R.W. et al. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling // Genet. Med. – 2011. – Vol. 13, Iss. 5. – P. 385–391.
  31. Warren J.L., Klabunde C.N., Mariotto A.B. et al. Adverse events after outpatient colonoscopy in the Medicare population // Ann. Intern. Med. – 2009. – Vol. 150, N 12. – P. 849–857.
  32. Weinberg D.S., Barkun A., Turner B.J. Colorectal Cancer Screening in the United States: What Is the Best FIT? // Ann. Intern Med. – 2017. – Vol. 166, N 4. – P. 297–298.
  33. Weissfeld J.L., Schoen R.E., Pinsky P.F. et al. Flexible sigmoidoscopy in the PLCO cancer screening. Trial: results from the baseline screening examination of a randomized trial // J. Nat. Cancer Inst. – 2005. – Vol. 97, N 13. – P. 989–997.
  34. Willett W.C. Diet and cancer: an evolving picture // JAMA. – 2005. – Vol. 293, N 2. – P. 233–234.
  35. Wilt T.J., Harris R.P., Qaseem A. High Value Care Task Force of the American College of Physicians. Screening for cancer: advice for high-value care from the American College of Physicians // Ann. Intern. Med. – 2015. – Vol. 162, N 10. – P. 718–725.
  36. Winawer S.J., Fletcher R.H., Miller L. et al. Colorectal cancer screening: clinical guidelines and rationale // Gastroenterology. – 1997. – Vol. 112, Iss. 2. – P. 594–642.
  37. Winawer S., Glassen M., Lambert R. et al. Colorectal cancer screening 2007. – P. 1–18.
  38. Wolf A.M.D., Fonthan E.T.H., Church T.R. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society // CA: A Cancer J. for Clinicians. – 2018. – Vol. 68, Iss. 4. – P. 250–281.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Minskiy R.V.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies